Stockysis Logo
  • Login
  • Register
Back to News

HC Wainwright & Co. Assumes Citius Pharmaceuticals at Buy, Announces Price Target of $4

Benzinga Newsdesk www.benzinga.com Positive 66.8%
Neg 0% Neu 0% Pos 66.8%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us